Acuta Capital Erasca Bets Big on Targeted Cancer Therapies
A niche investment move places acuta capital erasca (eras) at the center of Erasca's ambitious quest in targeted canc...
This introductory paragraph highlights how yearly drawdown data for index funds reveals cyclic risk patterns and guides more resilient investment choices.
25,260 articlesA niche investment move places acuta capital erasca (eras) at the center of Erasca's ambitious quest in targeted canc...
A data center spending surge across AI giants is reshaping markets. This article explains how a single company could ...
When memory stocks spark market optimism, chipmakers can drive broader gains. This piece breaks down what’s behind th...
A major hedge fund just disclosed a multi-million stake in Crinetics, a rare-disease biotech. This article unpacks wh...
A top healthcare fund just lined up another $11 million in a biotech that’s surged 60%. We break down why the move ma...
Alphabet is stepping up its AI game, signaling big potential and bigger risks for investors. This piece breaks down w...
Wall Street leaned on a familiar Fed playbook for years. Now a surprising pivot in that script could rattle stocks an...
Bitcoin sits at a crossroads as CPI data on June 10 and the FOMC dot plot on June 17 collide in a tight seven-day win...
As summer kicks off, the 2027 cola calculation officially begins its data-driven cycle. Learn what to watch, how it a...
NVIDIA just reported billion-dollar revenue, underscoring a surge in AI infrastructure spending. This article explain...
Tech names surged as AI infrastructure demand strengthens revenue outlook. This article breaks down what happened, wh...
A little-known Fidelity fund is posting strong returns as demand for electrification and data-center power infrastruc...